We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+3.05%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$820M
AUM Growth
+$18.2M
Cap. Flow
+$4.61M
Cap. Flow %
0.56%
Top 10 Hldgs %
75.36%
Holding
109
New
14
Increased
6
Reduced
15
Closed
18

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$28.5M
2
DIS icon
Walt Disney
DIS
+$24.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$21.1M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$15.5M
5
AAPL icon
Apple
AAPL
+$8M

Top Sells

Rank Stock Value
1
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
+$3.65M
2
PFE icon
Pfizer
PFE
+$3.35M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.65M
4
EEQ
Enbridge Energy Management Llc
EEQ
+$2.47M
5
IBM icon
IBM
IBM
+$552K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 48.99%
2 Healthcare 21.47%
3 Energy 13.94%
4 Consumer Staples 5.51%
5 Communication Services 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$394M 48.04%
9,884,936
+41,000
+0.4% +$1.63M
KMI icon
2
Kinder Morgan
KMI
$70.1B
$58.6M 7.15%
1,393,757
-6,692
-0.5% -$277K
BMY icon
3
Bristol-Myers Squibb
BMY
$130B
$29.4M 3.58%
+455,152
New +$28.5M
DIS icon
4
Walt Disney
DIS
$179B
$25.9M 3.15%
+246,600
New +$24.9M
PFE icon
5
Pfizer
PFE
$152B
$21.2M 2.58%
641,175
-105,400
-14% -$3.35M
JNJ icon
6
Johnson & Johnson
JNJ
$626B
$20.9M 2.54%
+207,400
New +$21.1M
ZTS icon
7
Zoetis
ZTS
$31.1B
$19M 2.32%
411,420
-10,000
-2% -$451K
MJN
8
DELISTED
Mead Johnson Nutrition Company
MJN
$17.3M 2.11%
171,728
– –
ESRX
9
DELISTED
Express Scripts Holding Company
ESRX
$16.3M 1.98%
187,286
-272
-0.1% -$22.8K
SIAL
10
DELISTED
SIGMA - ALDRICH CORP
SIAL
$15.6M 1.9%
+112,700
New +$15.5M
ABBV icon
11
AbbVie
ABBV
$442B
$15M 1.82%
255,560
-1,400
-0.5% -$84.6K
LLY icon
12
Eli Lilly
LLY
$1.08T
$14.3M 1.75%
197,400
– –
ZBH icon
13
Zimmer Biomet
ZBH
$18.5B
$14.1M 1.71%
123,240
-1,545
-1% -$176K
ABT icon
14
Abbott
ABT
$190B
$12M 1.47%
259,560
-1,400
-0.5% -$64.3K
KMB icon
15
Kimberly-Clark
KMB
$36.1B
$11.3M 1.38%
105,700
– –
TCP
16
DELISTED
TC Pipelines LP
TCP
$11.2M 1.37%
172,650
– –
PM icon
17
Philip Morris
PM
$290B
$8.66M 1.06%
115,024
+540
+0.5% +$43.8K
GE icon
18
GE Aerospace
GE
$382B
$8.45M 1.03%
71,058
– –
AAPL icon
19
Apple
AAPL
$4.45T
$8.24M 1%
+264,888
New +$8M
BAX icon
20
Baxter International
BAX
$14.3B
$8.23M 1%
221,288
+43,816
+25% +$1.66M
EPD icon
21
Enterprise Products Partners
EPD
$81.8B
$7.75M 0.94%
235,218
+4,000
+2% +$134K
PG icon
22
Procter & Gamble
PG
$338B
$6.99M 0.85%
85,319
– –
MMP
23
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.66M 0.81%
86,800
– –
TPR icon
24
Tapestry
TPR
$32.4B
$6.63M 0.81%
160,000
– –
EEQ
25
DELISTED
Enbridge Energy Management Llc
EEQ
$6.18M 0.75%
241,571
-95,805
-28% -$2.47M
1
2 3 4

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Blackhill Capital held 109 positions worth $820M, up 2.3% from $802M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Blackhill Capital's Q1 2015 filing shows 14 new, 6 increased, 15 reduced and 18 closed positions. Its largest new stake was Bristol-Myers Squibb: 455,152 shares worth $29.4M. The largest sale was WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT, an estimated $3.65M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Energy.

  • Blackhill Capital's largest Q1 2015 buy was Bristol-Myers Squibb: 455,152 shares worth $29.4M.
  • Blackhill Capital added most to Baxter International in Q1 2015, an estimated $1.66M increase.
  • Blackhill Capital's biggest Q1 2015 reduction was Pfizer, cutting an estimated $3.35M.
  • Blackhill Capital fully exited WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT in Q1 2015, selling an estimated $3.65M.
  • Blackhill Capital's ten largest holdings make up 75% of its $820M portfolio in Q1 2015.
  • Blackhill Capital opened 14 new positions and closed 18 in Q1 2015.
  • Blackhill Capital's portfolio value rose 2.3% quarter-over-quarter to $820M.

Based on Blackhill Capital's 13F filing for Q1 2015, filed 7 May 2015.